[SLN] YoY Annual Result on 31-Dec-2022 [#FY]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
15-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#FY]
Profit Trend
YoY- -2.74%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 25,375 17,501 12,415 5,479 244 0 16 241.30%
PBT -50,310 -47,368 -45,856 -36,041 -22,870 -20,526 -3,775 53.94%
Tax -7,043 -6,879 -6,446 -3,494 -3,288 -2,115 -2,157 21.79%
NP -43,267 -40,489 -39,410 -32,547 -19,582 -18,411 -1,618 72.88%
Tax Rate - - - - - - - -
Total Cost 68,642 57,990 51,825 38,026 19,826 18,411 1,634 86.39%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -170.51 -231.35 -317.44 -594.03 -8,025.41 0.00 -10,112.50 -49.34%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -1.17 -1.26 -1.33 -1.19 -0.78 -0.79 -0.07 59.86%
EPS Diluted -1.17 -1.26 -1.33 -1.19 -0.78 -0.79 -0.07 59.86%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.